Recall: D-0439-2026

Class II - Potentially Harmful

Class IIClassification

2026-03-20Initiated

OngoingStatus

Fagron Compounding ServicesFirm

Product

norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5027-02

Reason

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Distribution

Nationwide in the U.S.A.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.